Why This Matters for Your Career
Hetero is hiring 6 roles related to this product
Company
Hetero
India - Hyderabad
SOLRIAMFETOL (solriamfetol) by Hetero is dopamine uptake inhibitors [moa].
Drug data last refreshed 8h ago
Dopamine Uptake Inhibitors
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
A Study to Assess the Efficacy and Safety of Solriamfetol in Children With ADHD
A Study to Assess the Efficacy and Safety of Solriamfetol in Adolescents With ADHD
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Open-Label Safety Study of Solriamfetol in Subjects With Binge Eating Disorder
Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
Worked on SOLRIAMFETOL at Hetero? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Hetero is hiring 6 roles related to this product